(Q42958110)

11 November 2017

title

Lithium for older adults with bipolar disorder: Should it still be considered a first-line agent? (English)

1 reference

11 November 2017

1 reference

Kenneth I Shulman

1

1 reference

11 November 2017

publication date

1 August 2010

1 reference

11 November 2017

number of pages

9

1 reference

inferred from page(s)

published in

Drugs & Aging

1 reference

11 November 2017

volume

27

1 reference

11 November 2017

issue

8

1 reference

11 November 2017

page(s)

607-615

1 reference

Lithium-associated hyperparathyroidism: report of four cases and review of the literature

11 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11537700-000000000-00000

A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic?

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11537700-000000000-00000

Experience with the Atypical Antipsychotics - Risperidone and Olanzapine in the Elderly

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11537700-000000000-00000

Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease

21 January 2018

1 reference

12 December 2020

Suicide risk in bipolar disorder during treatment with lithium and divalproex

1 reference

12 December 2020

Managing bipolar disorder in the elderly: defining the role of the newer agents

1 reference

12 December 2020

Renal insufficiency in long-term lithium treatment

1 reference

12 December 2020

Lithium treatment and risk of dementia.

1 reference

12 December 2020

Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate.

1 reference

12 December 2020

Treatment of elderly institutionalized bipolar patients with clozapine

1 reference

12 December 2020

Bipolar disorder center for Pennsylvanians: implementing an effectiveness trial to improve treatment for at-risk patients

1 reference

12 December 2020

Lithium-induced nephropathy: Rate of progression and prognostic factors

1 reference

12 December 2020

Prescription patterns of psychotropic medications in elderly compared with younger participants who achieved a "recovered" status in the systematic treatment enhancement program for bipolar disorder

1 reference

12 December 2020

Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder?

1 reference

12 December 2020

The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients

1 reference

12 December 2020

Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?

1 reference

12 December 2020

The effect of prophylactic lithium treatment on mortality and suicidal behavior: a review for clinicians

1 reference

12 December 2020

The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.

1 reference

12 December 2020

Brain lithium levels and effects on cognition and mood in geriatric bipolar disorder: a lithium-7 magnetic resonance spectroscopy study

1 reference

12 December 2020

Experience with the atypical antipsychotics--risperidone and olanzapine in the elderly

1 reference

12 December 2020

Lithium for maintenance treatment of mood disorders

1 reference

12 December 2020

Renal effects of long-term lithium therapy in the elderly: a cross-sectional study.

1 reference

12 December 2020

Do atypical antipsychotics cause stroke?

1 reference

12 December 2020

Suicide risk in patients treated with lithium

1 reference

12 December 2020

Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder

1 reference

12 December 2020

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.

1 reference

12 December 2020

Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy

1 reference

12 December 2020

Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series

1 reference

12 December 2020

Mortality of patients with mood disorders: follow-up over 34-38 years

1 reference

12 December 2020

Lithium and dementia: a preliminary study

1 reference

12 December 2020

The British Association for Psychopharmacology guidelines for treatment of bipolar disorder: a summary.

1 reference

12 December 2020

The impact of long-term lithium treatment on renal function in an outpatient population

1 reference

12 December 2020

A feasibility and tolerability study of lithium in Alzheimer's disease.

1 reference

12 December 2020

Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial

1 reference

12 December 2020

Antidepressants for bipolar depression: a systematic review of randomized, controlled trials

1 reference

12 December 2020

Lithium-induced increase in human brain grey matter

1 reference

12 December 2020

The antisuicidal and mortality-reducing effect of lithium prophylaxis: consequences for guidelines in clinical psychiatry.

1 reference

12 December 2020

Lithium for prevention of Alzheimer's disease.

1 reference

12 December 2020

Lithium may be useful in the prevention of Alzheimer's disease in individuals at risk of presenile familial Alzheimer's disease

1 reference

12 December 2020

Attitudes of old age psychiatrists in England and Wales to the use of mood stabilizer drugs

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

1 reference

12 December 2020

The longitudinal course of cognition in older adults with bipolar disorder

1 reference

12 December 2020

Quetiapine for the treatment of bipolar mania in older adults

1 reference

12 December 2020

Evidence-based pharmacological treatment of geriatric bipolar disorder.

1 reference

12 December 2020

Pharmacotherapy of bipolar disorder in old age: review and recommendations

1 reference

12 December 2020

Clozapine in rapid cycling bipolar disorder

1 reference

12 December 2020

Treating the suicidal patient with bipolar disorder. Reducing suicide risk with lithium

1 reference

12 December 2020

Does lithium therapy protect against the onset of dementia?

1 reference

12 December 2020

Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence.

1 reference

12 December 2020

Treatments for late-life bipolar disorder

1 reference

12 December 2020

Monitoring of glomerular filtration rate in lithium-treated outpatients--an ambulatory laboratory database surveillance

1 reference

12 December 2020

Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial

1 reference

12 December 2020

Drug-Induced Lithium Toxicity in the Elderly: A Population-Based Study

1 reference

12 December 2020

Maintenance treatment outcomes in older patients with bipolar I disorder

1 reference

12 December 2020

New thyroxine treatment in older adults beginning lithium therapy: implications for clinical practice

1 reference

12 December 2020

A pilot study of standardized treatment in geriatric bipolar disorder.

1 reference

12 December 2020

10.2165/11537700-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

11 November 2017

1015098055

0 references

1 reference